RU2008144958A - Адгезивный препарат - Google Patents
Адгезивный препарат Download PDFInfo
- Publication number
- RU2008144958A RU2008144958A RU2008144958/15A RU2008144958A RU2008144958A RU 2008144958 A RU2008144958 A RU 2008144958A RU 2008144958/15 A RU2008144958/15 A RU 2008144958/15A RU 2008144958 A RU2008144958 A RU 2008144958A RU 2008144958 A RU2008144958 A RU 2008144958A
- Authority
- RU
- Russia
- Prior art keywords
- adhesive
- adhesive preparation
- plasma
- range
- adhesive layer
- Prior art date
Links
- 239000000853 adhesive Substances 0.000 title claims abstract 22
- 230000001070 adhesive effect Effects 0.000 title claims abstract 22
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000012790 adhesive layer Substances 0.000 claims abstract 15
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims abstract 14
- 239000010410 layer Substances 0.000 claims abstract 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract 8
- 229960001047 methyl salicylate Drugs 0.000 claims abstract 6
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims abstract 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract 4
- 229960004889 salicylic acid Drugs 0.000 claims abstract 4
- 239000000463 material Substances 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims abstract 2
- 230000035699 permeability Effects 0.000 claims abstract 2
- 229920002725 thermoplastic elastomer Polymers 0.000 claims 3
- 239000011347 resin Substances 0.000 claims 2
- 229920005989 resin Polymers 0.000 claims 2
- ROGIWVXWXZRRMZ-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1 ROGIWVXWXZRRMZ-UHFFFAOYSA-N 0.000 claims 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims 1
- 239000005062 Polybutadiene Substances 0.000 claims 1
- 229920002367 Polyisobutene Polymers 0.000 claims 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims 1
- FACXGONDLDSNOE-UHFFFAOYSA-N buta-1,3-diene;styrene Chemical compound C=CC=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 FACXGONDLDSNOE-UHFFFAOYSA-N 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 229920003049 isoprene rubber Polymers 0.000 claims 1
- 229920002857 polybutadiene Polymers 0.000 claims 1
- 229920001195 polyisoprene Polymers 0.000 claims 1
- 229920003048 styrene butadiene rubber Polymers 0.000 claims 1
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 claims 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F15/00—Auxiliary appliances for wound dressings; Dispensing containers for dressings or bandages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B7/00—Layered products characterised by the relation between layers; Layered products characterised by the relative orientation of features between layers, or by the relative values of a measurable parameter between layers, i.e. products comprising layers having different physical, chemical or physicochemical properties; Layered products characterised by the interconnection of layers
- B32B7/04—Interconnection of layers
- B32B7/12—Interconnection of layers using interposed adhesives or interposed materials with bonding properties
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/28—Web or sheet containing structurally defined element or component and having an adhesive outermost layer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/28—Web or sheet containing structurally defined element or component and having an adhesive outermost layer
- Y10T428/2852—Adhesive compositions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
- Y10T442/2738—Coating or impregnation intended to function as an adhesive to solid surfaces subsequently associated therewith
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/30—Woven fabric [i.e., woven strand or strip material]
- Y10T442/3472—Woven fabric including an additional woven fabric layer
- Y10T442/3528—Three or more fabric layers
- Y10T442/3561—Woven fabric layers impregnated with a natural or synthetic rubber
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Botany (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1. Адгезивный препарат, содержащий поддающуюся растягиванию основу и адгезивный слой, нанесенный тонким слоем по меньшей мере на одну сторону основы, где ! поддающаяся растягиванию основа содержит соединительный слой тканого материала, подвергнутый процессу гофрирования, ! адгезивный слой содержит 10% по массе или более метилсалицилата из расчета на общую массу слоя, ! влагопроницаемость всего адгезивного препарата составляет 1-350 г/м2·24 ч, измеренную при температуре 40°C и относительной влажности 90%, и ! метилсалицилат имеет AUC0-24 в плазме в интервале от 3,0 до 60,0 нг·ч/мл в значениях среднего±стандартное отклонение, и салициловая кислота в качестве метаболита метилсалицилата имеет AUC0-24 в плазме в интервале от 5000 до 13000 нг·ч/мл в значениях среднего±стандартное отклонение, когда адгезивный препарат накладывают на кожу человека на 8 ч, таким образом, что наносимое количество адгезивного слоя составляет 50-300 г/м2, и площадь контакта составляет 280 см2. ! 2. Адгезивный препарат по п.1, где ! метилсалицилат имеет Cmax в плазме в интервале от 2,0 до 40,0 нг/мл в значениях среднего±стандартное отклонение, салициловая кислота имеет Cmax в плазме в интервале от 700 до 2000 нг/мл в значениях среднего±стандартное отклонение, когда адгезивный препарат накладывают на кожу человека на 8 ч, таким образом, что наносимое количество адгезивного слоя составляет 50-300 г/м2, и площадь контакта составляет 280 см2. ! 3. Адгезивный препарат по п.1, где адгезивный слой содержит 1% по массе или более 1-ментола, из расчета на общую массу слоя. ! 4. Адгезивный препарат по п.3, где 1-ментол имеет AUC0-24 в плазме в интервале от 30,0 до 130,0 нг·ч/мл в значениях среднего±стандартное отк
Claims (10)
1. Адгезивный препарат, содержащий поддающуюся растягиванию основу и адгезивный слой, нанесенный тонким слоем по меньшей мере на одну сторону основы, где
поддающаяся растягиванию основа содержит соединительный слой тканого материала, подвергнутый процессу гофрирования,
адгезивный слой содержит 10% по массе или более метилсалицилата из расчета на общую массу слоя,
влагопроницаемость всего адгезивного препарата составляет 1-350 г/м2·24 ч, измеренную при температуре 40°C и относительной влажности 90%, и
метилсалицилат имеет AUC0-24 в плазме в интервале от 3,0 до 60,0 нг·ч/мл в значениях среднего±стандартное отклонение, и салициловая кислота в качестве метаболита метилсалицилата имеет AUC0-24 в плазме в интервале от 5000 до 13000 нг·ч/мл в значениях среднего±стандартное отклонение, когда адгезивный препарат накладывают на кожу человека на 8 ч, таким образом, что наносимое количество адгезивного слоя составляет 50-300 г/м2, и площадь контакта составляет 280 см2.
2. Адгезивный препарат по п.1, где
метилсалицилат имеет Cmax в плазме в интервале от 2,0 до 40,0 нг/мл в значениях среднего±стандартное отклонение, салициловая кислота имеет Cmax в плазме в интервале от 700 до 2000 нг/мл в значениях среднего±стандартное отклонение, когда адгезивный препарат накладывают на кожу человека на 8 ч, таким образом, что наносимое количество адгезивного слоя составляет 50-300 г/м2, и площадь контакта составляет 280 см2.
3. Адгезивный препарат по п.1, где адгезивный слой содержит 1% по массе или более 1-ментола, из расчета на общую массу слоя.
4. Адгезивный препарат по п.3, где 1-ментол имеет AUC0-24 в плазме в интервале от 30,0 до 130,0 нг·ч/мл в значениях среднего±стандартное отклонение и Cmax в плазме в интервале от 5,0 до 20,0 нг/мл в значениях среднего±стандартное отклонение, когда адгезивный препарат накладывают на кожу человека на 8 ч, таким образом, что наносимое количество адгезивного слоя составляет 50-300 г/м2, и площадь контакта составляет 280 см2.
5. Адгезивный препарат по п.1, где тканый материал имеет массу 80-150 г/м2.
6. Адгезивный препарат по п.1, где адгезивный слой содержит термопластичный эластомер.
7. Адгезивный препарат по п.6, где термопластичный эластомер представляет собой один или два или более видов, выбранных из группы, состоящей из блок сополимера стирол-изопрен-стирола, блок сополимера стирол-бутадиен-стирола, стирол-изопренового каучука, стирол-бутадиенового каучука, полиизопрена, полибутадиена и полиизобутилена.
8. Адгезивный препарат по п.6, где содержание термопластичного эластомера составляет от 25 до 50% по массе, из расчета на общую массу адгезивного слоя.
9. Адгезивный препарат по п.1, где адгезивный слой содержит смолу на канифолевой основе и/или смолу на нефтяной основе в качестве усилителя клейкости.
10. Адгезивный препарат по п.9, где содержание усилителя клейкости составляет от 10 до 30% по массе, из расчета на общую массу адгезивного слоя.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006-213670 | 2006-08-04 | ||
| JP2006213670 | 2006-08-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2008144958A true RU2008144958A (ru) | 2010-05-20 |
| RU2441649C2 RU2441649C2 (ru) | 2012-02-10 |
Family
ID=38997252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008144958A RU2441649C2 (ru) | 2006-08-04 | 2007-08-01 | Адгезивный препарат |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US8455376B2 (ru) |
| EP (1) | EP2047845B1 (ru) |
| JP (1) | JP5230423B2 (ru) |
| KR (1) | KR101420450B1 (ru) |
| CN (1) | CN101442993B (ru) |
| AU (1) | AU2007279643B2 (ru) |
| BR (1) | BRPI0712396B8 (ru) |
| CA (1) | CA2652220C (ru) |
| ES (1) | ES2755027T3 (ru) |
| HU (1) | HUE047985T2 (ru) |
| MX (1) | MX2008014574A (ru) |
| MY (1) | MY149142A (ru) |
| NZ (1) | NZ572705A (ru) |
| RU (1) | RU2441649C2 (ru) |
| SG (1) | SG174034A1 (ru) |
| TW (1) | TWI414299B (ru) |
| WO (1) | WO2008016077A1 (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2008014574A (es) | 2006-08-04 | 2009-02-06 | Hisamitsu Pharmaceutical Co | Preparacion adhesiva. |
| DE102009006591A1 (de) * | 2009-01-29 | 2010-08-05 | Tesa Se | Haftklebemasse |
| JP5860201B2 (ja) * | 2010-02-12 | 2016-02-16 | 久光製薬株式会社 | 経皮吸収製剤並びにその製造方法 |
| JP6014813B2 (ja) * | 2010-09-03 | 2016-10-26 | 株式会社 ケイ・エム トランスダーム | 経皮吸収製剤および皮膚貼付用粘着シート |
| EP2999594A4 (en) * | 2013-05-23 | 2016-12-21 | Henkel IP & Holding GmbH | MULTILAYER BARRIER ADHESIVE FOIL |
| FR3039991A1 (fr) * | 2015-08-12 | 2017-02-17 | Ab7 Innovation | Composition antidouleur comprenant un derive de l'acide salicylique |
| ES2893527T3 (es) * | 2016-12-28 | 2022-02-09 | Hisamitsu Pharmaceutical Co | Parche |
| TWI818905B (zh) * | 2017-03-20 | 2023-10-21 | 荷蘭商帝斯曼知識產權資產管理有限公司 | 三維成形製品及其製備方法 |
| WO2019142940A1 (ja) * | 2018-01-22 | 2019-07-25 | 株式会社カネカ | 皮膚貼付用粘着シート |
| CN113474043B (zh) * | 2019-02-27 | 2024-05-14 | 久光制药株式会社 | 贴剂 |
| US11872320B2 (en) | 2021-02-25 | 2024-01-16 | Hisamitsu Pharmaceutical Co., Inc. | Method for treating osteoarthritis |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54143517A (en) * | 1978-04-28 | 1979-11-08 | Hisamitsu Pharmaceut Co Inc | Novel poultice and its preparation |
| GB2045618B (en) * | 1979-04-03 | 1983-05-11 | Hisamitsu Pharmaceutical Co | Adhesive plaster |
| KR970009886B1 (ko) | 1981-08-30 | 1997-06-19 | 히사미쯔세이야꾸 가부시기가이샤 | 소염진통 첩부제 |
| US4867150A (en) * | 1987-01-20 | 1989-09-19 | The B. F. Goodrich Company | Perforated elastomeric soft film and wound dressing made therewith |
| JPS63222113A (ja) * | 1987-03-11 | 1988-09-16 | Kao Corp | 貼付剤組成物 |
| JP2563846B2 (ja) * | 1990-06-28 | 1996-12-18 | バンドー化学株式会社 | 粘着シート |
| JPH0651244A (ja) | 1992-07-27 | 1994-02-25 | Fuji Elelctrochem Co Ltd | 偏波多重装置 |
| JPH06260709A (ja) | 1993-03-03 | 1994-09-16 | Fujitsu Ltd | 光増幅器、光増幅多中継システム及び光増幅多中継システムの制御方法 |
| JP3250206B2 (ja) | 1994-02-14 | 2002-01-28 | 住友電気工業株式会社 | 光ファイバ増幅器 |
| US5536263A (en) | 1994-03-30 | 1996-07-16 | Lectec Corporation | Non-occulusive adhesive patch for applying medication to the skin |
| TW411277B (en) * | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
| US6620430B2 (en) | 1996-12-06 | 2003-09-16 | Hisamitsu Pharmaceutical Co., Inc. | Plaster containing felbinac |
| WO1998024423A1 (en) | 1996-12-06 | 1998-06-11 | Hisamitsu Pharmaceutical Co., Inc. | Felbinac-containing patch |
| JP2000049406A (ja) | 1998-07-31 | 2000-02-18 | Hitachi Cable Ltd | 光ファイバ増幅器 |
| JP3901859B2 (ja) | 1998-10-04 | 2007-04-04 | 古河電気工業株式会社 | 光増幅器 |
| JP2000244417A (ja) | 1999-02-22 | 2000-09-08 | Nec Eng Ltd | 光前置増幅器 |
| JP4584381B2 (ja) | 1999-07-30 | 2010-11-17 | 久光製薬株式会社 | フェルビナク含有貼付剤 |
| JP2001044557A (ja) | 1999-08-04 | 2001-02-16 | Mitsubishi Electric Corp | 光ファイバ増幅装置および励起光生成回路 |
| CN1235572C (zh) | 1999-12-15 | 2006-01-11 | 久光制药株式会社 | 贴剂 |
| JP2001313433A (ja) | 2000-02-23 | 2001-11-09 | Fujitsu Ltd | 光増幅器及び光増幅方法 |
| CA2424579C (en) * | 2000-03-17 | 2009-11-03 | Hisamitsu Pharmaceuticals Co., Inc. | Ultraviolet-screening patch |
| JP2001328935A (ja) | 2000-05-19 | 2001-11-27 | Hisamitsu Pharmaceut Co Inc | 貼付剤 |
| JP2003031879A (ja) | 2001-07-16 | 2003-01-31 | Mitsubishi Cable Ind Ltd | 光学装置及び該光学装置に用いられる光ファイバ、並びにパルス発生装置、光増幅装置及びファイバレーザ装置 |
| JP2003169823A (ja) * | 2001-09-27 | 2003-06-17 | Lion Corp | 貼付剤 |
| JP2004146681A (ja) | 2002-10-25 | 2004-05-20 | Sumitomo Electric Ind Ltd | 光増幅用ファイバ、光増幅装置、光源装置、光治療装置および露光装置 |
| TWI327074B (en) | 2003-05-07 | 2010-07-11 | Hisamitsu Pharmaceutical Co | Ultra violet shielding patch |
| KR101045785B1 (ko) * | 2003-10-20 | 2011-07-04 | 히사미쓰 제약주식회사 | 피부외용 첩부제 |
| WO2005092265A1 (ja) | 2004-03-29 | 2005-10-06 | Hisamitsu Pharmaceutical Co., Inc. | 貼付剤 |
| JP4812268B2 (ja) * | 2004-08-03 | 2011-11-09 | リンテック株式会社 | 揮発抑制剤、揮発性成分含有組成物および貼付剤 |
| US20060263420A1 (en) | 2005-03-10 | 2006-11-23 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive and plaster |
| CA2599290C (en) | 2005-03-10 | 2013-11-12 | Hisamitsu Pharmaceutical Co., Inc. | Ketoprofen sis adhesive for skin adhesive plaster |
| JP2007015963A (ja) | 2005-07-06 | 2007-01-25 | Hisamitsu Pharmaceut Co Inc | 貼付剤 |
| JP5129925B2 (ja) | 2005-12-07 | 2013-01-30 | 久光製薬株式会社 | 貼付剤 |
| MX2008014574A (es) * | 2006-08-04 | 2009-02-06 | Hisamitsu Pharmaceutical Co | Preparacion adhesiva. |
-
2007
- 2007-08-01 MX MX2008014574A patent/MX2008014574A/es active IP Right Grant
- 2007-08-01 HU HUE07791748A patent/HUE047985T2/hu unknown
- 2007-08-01 NZ NZ572705A patent/NZ572705A/en unknown
- 2007-08-01 JP JP2008527771A patent/JP5230423B2/ja active Active
- 2007-08-01 WO PCT/JP2007/065067 patent/WO2008016077A1/ja not_active Ceased
- 2007-08-01 MY MYPI20084495A patent/MY149142A/en unknown
- 2007-08-01 AU AU2007279643A patent/AU2007279643B2/en active Active
- 2007-08-01 BR BRPI0712396A patent/BRPI0712396B8/pt active IP Right Grant
- 2007-08-01 EP EP07791748.2A patent/EP2047845B1/en active Active
- 2007-08-01 KR KR1020087027800A patent/KR101420450B1/ko active Active
- 2007-08-01 SG SG2011055878A patent/SG174034A1/en unknown
- 2007-08-01 CA CA 2652220 patent/CA2652220C/en active Active
- 2007-08-01 RU RU2008144958A patent/RU2441649C2/ru active
- 2007-08-01 CN CN2007800175841A patent/CN101442993B/zh active Active
- 2007-08-01 US US12/227,066 patent/US8455376B2/en active Active
- 2007-08-01 ES ES07791748T patent/ES2755027T3/es active Active
- 2007-08-03 TW TW96128615A patent/TWI414299B/zh active
-
2009
- 2009-10-26 US US12/588,721 patent/US8809615B2/en active Active
-
2014
- 2014-07-08 US US14/326,014 patent/US9233184B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0712396B8 (pt) | 2021-05-25 |
| AU2007279643B2 (en) | 2012-09-13 |
| EP2047845A1 (en) | 2009-04-15 |
| EP2047845B1 (en) | 2019-10-09 |
| US8455376B2 (en) | 2013-06-04 |
| CA2652220A1 (en) | 2008-02-07 |
| JP5230423B2 (ja) | 2013-07-10 |
| US8809615B2 (en) | 2014-08-19 |
| KR20090035474A (ko) | 2009-04-09 |
| KR101420450B1 (ko) | 2014-07-16 |
| BRPI0712396A8 (pt) | 2020-03-24 |
| TW200817013A (en) | 2008-04-16 |
| MX2008014574A (es) | 2009-02-06 |
| JPWO2008016077A1 (ja) | 2009-12-24 |
| CN101442993A (zh) | 2009-05-27 |
| HUE047985T2 (hu) | 2020-05-28 |
| EP2047845A4 (en) | 2013-10-30 |
| CA2652220C (en) | 2014-07-08 |
| WO2008016077A1 (fr) | 2008-02-07 |
| US20090149794A1 (en) | 2009-06-11 |
| MY149142A (en) | 2013-07-15 |
| BRPI0712396A2 (pt) | 2012-10-16 |
| ES2755027T3 (es) | 2020-04-21 |
| BRPI0712396B1 (pt) | 2020-04-22 |
| SG174034A1 (en) | 2011-09-29 |
| CN101442993B (zh) | 2011-10-05 |
| NZ572705A (en) | 2011-12-22 |
| US20100047328A1 (en) | 2010-02-25 |
| US20140371693A1 (en) | 2014-12-18 |
| US9233184B2 (en) | 2016-01-12 |
| RU2441649C2 (ru) | 2012-02-10 |
| AU2007279643A1 (en) | 2008-02-07 |
| TWI414299B (zh) | 2013-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008144958A (ru) | Адгезивный препарат | |
| JPH04503357A (ja) | ニコチンの経皮デリバリー用デバイス | |
| JP2005502430A5 (ru) | ||
| RU98102410A (ru) | Нанесенный на ленту препарат для чрескожного введения, содержащий фентанил | |
| JP2016502989A5 (ru) | ||
| WO2011022199A3 (en) | Multi-layer transdermal patch | |
| JP2016520638A5 (ru) | ||
| CA2414239A1 (en) | Analgesic anti-inflammatory patch for topical application | |
| WO2011011318A8 (en) | Process for the continuous manufacture of a polyisobutylene based transdermal patch | |
| MX2013005581A (es) | Sistema terapeutico transdermico para la administracion de una sustancia activa. | |
| CA2502220A1 (en) | Transdermal patch for external use comprising fentanyl | |
| MY161056A (en) | Dental strip for administration of oral treatment | |
| US8382729B2 (en) | Adhesive patch | |
| DK1046395T3 (da) | Plaster indeholdende heparin og diclofenac til topisk anvendelse | |
| RU2009137122A (ru) | Устройство для трансдермального введения бисопролола | |
| CA2586871A1 (en) | Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic | |
| ATE354357T1 (de) | Transdermales therapeutisches system enthaltend leich flüchtige wirkstoffe | |
| NO20031211L (no) | Plaster omfattende diclofenac | |
| WO2005072669A1 (ja) | カバー材及びカバー材付き貼付剤 | |
| WO2012111996A3 (ko) | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 | |
| EP1686162A3 (en) | Tape Preparation | |
| CN203138857U (zh) | 一种硅胶创可贴 | |
| CN203195849U (zh) | 一种新型医用敷料 | |
| CN201912324U (zh) | 新型穴位给药药贴 | |
| CN108289859A (zh) | 用于透皮给药的系统和方法 |